Powered by
Generic drug maker expanding
Mar 9, 2017 - South Florida Sun-Sentinel

Apotex Corp., a Toronto-based maker of generic pharmaceutical drugs, announced Wednesday it will expand with a new $184 million research center and manufacturing plant in Miramar, which will also be its U.S. headquarters.

The Canadian manufacturer already has about 230 employees in Miramar and nearly 90 in Weston. The company said it plans at least 150 new jobs in Miramar.

"We can leverage on that existing infrastructure," said Jeremy Desai, CEO and president of Apotex. He said the c

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox